Functional precision medicine for patients with TCL using BH3 mimetic profiling. Functional profiling of T-cell lymphoma–derived cell lines was utilized to screen for cell susceptibilities to BH3 mimetics and BCL2 family inhibitors which can be used in combination with conventional chemotherapeutic agents. The figure has been adapted from the article by Koch et al that begins on page 566.